Johnson Matthey PLC (LON:JMAT - Get Free Report) shares hit a new 52-week high on Wednesday . The stock traded as high as GBX 1,873 ($25.27) and last traded at GBX 1,852.15 ($24.99), with a volume of 543474 shares trading hands. The stock had previously closed at GBX 1,852 ($24.98).
Johnson Matthey Trading Down 0.5%
The company has a market capitalization of £3.12 billion, a price-to-earnings ratio of 31.69, a P/E/G ratio of 49,242.50 and a beta of 0.95. The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 62.73. The company's 50 day simple moving average is GBX 1,644.58 and its two-hundred day simple moving average is GBX 1,455.14.
Johnson Matthey (LON:JMAT - Get Free Report) last announced its earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.01) earnings per share for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.49%. As a group, research analysts anticipate that Johnson Matthey PLC will post 173.4112903 earnings per share for the current fiscal year.
Insider Activity at Johnson Matthey
In related news, insider Liam Condon acquired 30 shares of the stock in a transaction dated Wednesday, April 16th. The stock was acquired at an average cost of GBX 1,200 ($16.19) per share, for a total transaction of £360 ($485.63). Insiders have acquired 62 shares of company stock worth $84,978 in the last three months. Insiders own 0.61% of the company's stock.
About Johnson Matthey
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Featured Articles
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
